title: Expression of collagen, interstitial collagenase, and tissue inhibitor of metalloproteinases-1 in restenosis after carotid endarterectomy.
abstract: Extracellular matrix is the principal component of the fibrous caps of atherosclerotic plaques and intimal hyperplastic lesions of reconstructed arteries. Interstitial collagen form an important part of the matrix, and the balance between collagen synthesis and degradation by interstitial collagenase (matrix metalloproteinase-1, MMP-1) may determine whether plaques rupture or vessels develop stenosis. We examined type I procollagen gene expression in human atherosclerotic and restenotic carotid arteries using in situ messenger RNA (mRNA) hybridization and the expression of MMP-1 and its endogenous inhibitor (tissue inhibitor of metalloproteinases-1, TIMP-1) by immunohistochemistry. Compared with normal arteries, atherosclerotic plaques bed increased expression of immunoreactive MMP-1 and TIMP-1 with modest increase of type 1 procollagen mRNA. Early restenotic lesions (< 1.5 years) contained abundant type I procollagen mRNA but little immunoreactive MMP-1 and TIMP-1. Late restenotic lesions (> 4 years) resembled atheroma and exhibited increased immunoreactive MMP-1 and TIMP-1 as well as abundant type I procollagen mRNA. Compared with atherosclerotic plaques, type I procollagen is increased and MMP-1 is decreased in early restenotic lesions. MMP-1 and TIMP-1 expressions are upregulated in lesions with a clear atheroma. These findings suggest that the balance between proteolysis and matrix synthesis may influence both the stability of atheromatous plaques and the development of restenotic lesions.
authors.affiliation: Department of Surgery, University of Washington, Seattle 98195-6410, USA.
authors.forename: S T
authors.initials: ST
authors.lastname: Nikkari
authors.forename: R L
authors.initials: RL
authors.lastname: Geary
authors.forename: T
authors.initials: T
authors.lastname: Hatsukami
authors.forename: M
authors.initials: M
authors.lastname: Ferguson
authors.forename: R
authors.initials: R
authors.lastname: Forough
authors.forename: C E
authors.initials: CE
authors.lastname: Alpers
authors.forename: A W
authors.initials: AW
authors.lastname: Clowes
mesh_terms: D001161:Arteriosclerosis / Q000378:metabolism / Q000473:pathology / Q000601:surgery; D016893:Carotid Stenosis / Q000378:metabolism* / Q000473:pathology / Q000601:surgery*; D003094:Collagen / Q000378:metabolism*; D017364:Collagenases / Q000378:metabolism*; D004691:Endarterectomy; D005110:Extracellular Space / Q000378:metabolism*; D006023:Glycoproteins / Q000378:metabolism*; D006801:Humans; D020781:Matrix Metalloproteinase 1; D061965:Matrix Metalloproteinase Inhibitors; D011347:Procollagen / Q000235:genetics / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D012008:Recurrence; D019714:Tissue Inhibitor of Metalloproteinases
chemical_list: D006023:Glycoproteins; D061965:Matrix Metalloproteinase Inhibitors; D011347:Procollagen; D012333:RNA, Messenger; D019714:Tissue Inhibitor of Metalloproteinases; D003094:Collagen; D017364:Collagenases; D020781:Matrix Metalloproteinase 1